Nonselective potassium channel blocker. Prepn: T. Katakami et al., EP 369627; eidem, US 5008267 (1990, 1991 both to Mitsui Toatsu Chem.); eidem, J. Med. Chem. 35, 3325 (1992). Pharmacology: J. Kamiya et al., Drug Dev. Res. 30, 37 (1993). Clinical experience: M. Igawa et al., J. Cardiovasc. Pharmacol. 40, 735 (2002); T. Minami et al., Pacing Clin. Electrophysiol. 27, 212 (2004). Review of pharmacology: H. Nakaya, H. Uemura, Cardiovasc. Drug Rev. 16, 133-144 (1998); of development and therapeutic potential: A. Zaza, Curr. Opin. Cardiovasc. Pulm. Renal Invest. Drugs 2, 86-94 (2000). Clinical evaluation in ventricular tachyarrhythmias: T. Katoh et al., Circ. J. 69, 1237 (2005); T. Washizuka et al., ibid. 1508; in shock-refractory ventricular fibrillation: Y. Tahara et al., ibid. 70, 442 (2006).
Antiarrhythmic (class III).
Antiarrhythmic; Potassium Channel Blocker